Tamara Alpermann

7.6k total citations
88 papers, 2.8k citations indexed

About

Tamara Alpermann is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Tamara Alpermann has authored 88 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Hematology, 45 papers in Genetics and 27 papers in Molecular Biology. Recurrent topics in Tamara Alpermann's work include Acute Myeloid Leukemia Research (74 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (28 papers) and Chronic Myeloid Leukemia Treatments (22 papers). Tamara Alpermann is often cited by papers focused on Acute Myeloid Leukemia Research (74 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (28 papers) and Chronic Myeloid Leukemia Treatments (22 papers). Tamara Alpermann collaborates with scholars based in Germany, United States and Austria. Tamara Alpermann's co-authors include Wolfgang Kern, Claudia Haferlach, Susanne Schnittger, Torsten Haferlach, Ulrike Bacher, Frank Dicker, Alexander Kohlmann, Vera Grossmann, Christiane Eder and Niroshan Nadarajah and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Tamara Alpermann

85 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamara Alpermann Germany 29 2.2k 1.3k 1.2k 443 421 88 2.8k
Christine L. O’Keefe United States 24 2.0k 0.9× 1.1k 0.9× 1.2k 1.0× 285 0.6× 348 0.8× 54 2.9k
Olivier Kosmider France 26 1.6k 0.7× 1.0k 0.8× 1.2k 1.0× 130 0.3× 294 0.7× 107 2.5k
Véronique Gelsi‐Boyer France 19 1.6k 0.7× 964 0.8× 1.2k 1.0× 169 0.4× 262 0.6× 28 2.1k
Vera Grossmann Germany 18 1.1k 0.5× 693 0.5× 757 0.6× 254 0.6× 281 0.7× 33 1.6k
Andrea Corbacioglu Germany 9 2.4k 1.1× 863 0.7× 1.3k 1.0× 708 1.6× 365 0.9× 21 2.7k
Olivier Nibourel France 19 1.1k 0.5× 669 0.5× 757 0.6× 258 0.6× 337 0.8× 55 1.6k
Francis Grand United Kingdom 20 1.3k 0.6× 1.1k 0.9× 1.3k 1.1× 117 0.3× 214 0.5× 36 2.3k
Hadrian Szpurka United States 17 1.4k 0.6× 972 0.8× 939 0.8× 128 0.3× 162 0.4× 35 2.0k
Zuzana Zemanová Czechia 22 987 0.4× 434 0.3× 744 0.6× 380 0.9× 235 0.6× 139 1.7k
Joannah Score United Kingdom 14 1.1k 0.5× 830 0.6× 1.3k 1.0× 162 0.4× 200 0.5× 23 2.1k

Countries citing papers authored by Tamara Alpermann

Since Specialization
Citations

This map shows the geographic impact of Tamara Alpermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Alpermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Alpermann more than expected).

Fields of papers citing papers by Tamara Alpermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Alpermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Alpermann. The network helps show where Tamara Alpermann may publish in the future.

Co-authorship network of co-authors of Tamara Alpermann

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara Alpermann. A scholar is included among the top collaborators of Tamara Alpermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara Alpermann. Tamara Alpermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kern, Wolfgang, Ulrike Bacher, Claudia Haferlach, et al.. (2016). Multiparameter Flow Cytometry Provides Independent Prognostic Information in Patients with Suspected Myelodysplastic Syndromes: A Study on 804 Patients. Cytometry Part B Clinical Cytometry.
2.
Cao, Qi, Micah D. Gearhart, Sigal Gery, et al.. (2016). BCOR regulates myeloid cell proliferation and differentiation. Leukemia. 30(5). 1155–1165. 66 indexed citations
3.
Kern, Wolfgang, Ulrike Bacher, Claudia Haferlach, et al.. (2015). Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients. Cytometry Part B Clinical Cytometry. 88(3). 154–164. 15 indexed citations
4.
Alpermann, Tamara, Ulrike Bacher, Christiane Eder, et al.. (2014). WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups. Leukemia. 29(3). 660–667. 57 indexed citations
5.
Eder, Christiane, Tamara Alpermann, Ulrike Bacher, et al.. (2014). High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome. Leukemia. 28(7). 1449–1458. 93 indexed citations
6.
Kern, Wolfgang, Ulrike Bacher, Susanne Schnittger, et al.. (2013). Multiparameter flow cytometry reveals myelodysplasia‐related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms. Cytometry Part B Clinical Cytometry. 84B(3). 194–197. 10 indexed citations
7.
Fasan, Annette, Claudia Haferlach, Tamara Alpermann, et al.. (2013). The role of different genetic subtypes of CEBPA mutated AML. Leukemia. 28(4). 794–803. 116 indexed citations
8.
Broséus, Julien, Tamara Alpermann, Michael Wulfert, et al.. (2013). Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis. Leukemia. 27(9). 1826–1831. 66 indexed citations
9.
Kohlmann, Alexander, Niroshan Nadarajah, Tamara Alpermann, et al.. (2013). Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease. Leukemia. 28(1). 129–137. 80 indexed citations
10.
Meggendorfer, Manja, Andreas Roller, Torsten Haferlach, et al.. (2012). SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood. 120(15). 3080–3088. 219 indexed citations
11.
Bacher, Ulrike, Wolfgang Kern, Tamara Alpermann, et al.. (2012). Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course. Leukemia Research. 36(7). 826–831. 8 indexed citations
12.
Schnittger, Susanne, Ulrike Bacher, Tamara Alpermann, et al.. (2012). Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases. Haematologica. 97(12). 1890–1894. 21 indexed citations
13.
Bellos, Frauke, Tamara Alpermann, Claudia Haferlach, et al.. (2012). Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patients. Cytometry Part B Clinical Cytometry. 82B(5). 295–304. 10 indexed citations
14.
Bacher, Ulrike, Torsten Haferlach, Tamara Alpermann, et al.. (2011). Subclones with the t(9;22)/BCR‐ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations. British Journal of Haematology. 152(6). 713–720. 41 indexed citations
15.
16.
Grossmann, Vera, Wolfgang Kern, Tamara Alpermann, et al.. (2011). Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia. Haematologica. 96(12). 1874–1877. 55 indexed citations
17.
Schnittger, Susanne, Ulrike Bacher, Wolfgang Kern, et al.. (2011). Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia. Leukemia. 25(8). 1297–1304. 79 indexed citations
18.
Weißmann, Sandra, Tamara Alpermann, Vera Grossmann, et al.. (2011). Landscape of TET2 mutations in acute myeloid leukemia. Leukemia. 26(5). 934–942. 183 indexed citations
19.
Bacher, Ulrike, Torsten Haferlach, Tamara Alpermann, et al.. (2010). Several lymphoma‐specific genetic events in parallel can be found in mature B‐cell neoplasms. Genes Chromosomes and Cancer. 50(1). 43–50. 23 indexed citations
20.
Schnittger, Susanne, Ulrike Bacher, Frank Dicker, et al.. (2010). Associations between imatinib resistance conferring mutations and Philadelphia positive clonal cytogenetic evolution in CML. Genes Chromosomes and Cancer. 49(10). 910–918. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine L. O’Keefe Breakdown of academic impact, for papers by Olivier Kosmider Breakdown of academic impact, for papers by Véronique Gelsi‐Boyer Breakdown of academic impact, for papers by Vera Grossmann Breakdown of academic impact, for papers by Andrea Corbacioglu Breakdown of academic impact, for papers by Olivier Nibourel Breakdown of academic impact, for papers by Francis Grand Breakdown of academic impact, for papers by Hadrian Szpurka Breakdown of academic impact, for papers by Zuzana Zemanová Breakdown of academic impact, for papers by Joannah Score
Rankless by CCL
2026